Page last updated: 2024-10-22

albendazole and Vasculitis

albendazole has been researched along with Vasculitis in 2 studies

Vasculitis: Inflammation of any one of the blood vessels, including the ARTERIES; VEINS; and rest of the vasculature system in the body.

Research Excerpts

ExcerptRelevanceReference
" This admission, she was treated with a combination of oral ivermectin (injectable solution form), with a dosage of 200-400 microg/kg/day, and albendazole for 14 days."5.32Disseminated strongyloidiasis successfully treated with extended duration ivermectin combined with albendazole: a case report of intractable strongyloidiasis. ( Niticharoenpong, K; Pornsuriyasak, P; Sakapibunnan, A, 2004)
" This admission, she was treated with a combination of oral ivermectin (injectable solution form), with a dosage of 200-400 microg/kg/day, and albendazole for 14 days."1.32Disseminated strongyloidiasis successfully treated with extended duration ivermectin combined with albendazole: a case report of intractable strongyloidiasis. ( Niticharoenpong, K; Pornsuriyasak, P; Sakapibunnan, A, 2004)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shaigany, S1
Dabela, E1
Teich, AF1
Husain, S1
Grossman, ME1
Pornsuriyasak, P1
Niticharoenpong, K1
Sakapibunnan, A1

Other Studies

2 other studies available for albendazole and Vasculitis

ArticleYear
Resolution of urticarial vasculitis after treatment of neurocysticercosis.
    Journal of the American Academy of Dermatology, 2015, Volume: 72, Issue:1

    Topics: Adult; Albendazole; Anthelmintics; Humans; Male; Neurocysticercosis; Remission Induction; Urticaria;

2015
Disseminated strongyloidiasis successfully treated with extended duration ivermectin combined with albendazole: a case report of intractable strongyloidiasis.
    The Southeast Asian journal of tropical medicine and public health, 2004, Volume: 35, Issue:3

    Topics: Albendazole; Animals; Anthelmintics; Drug Therapy, Combination; Feces; Female; Humans; Intestinal Di

2004